Department of Health and Human Services October 11, 2006 – Federal Register Recent Federal Regulation Documents

Recordkeeping Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material From Cattle
Document Number: E6-16830
Type: Rule
Date: 2006-10-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is requiring that manufacturers and processors of human food and cosmetics that are manufactured from, processed with, or otherwise contain, material from cattle establish and maintain records sufficient to demonstrate that the human food or cosmetic is not manufactured from, processed with, or does not otherwise contain, prohibited cattle materials. These recordkeeping requirements provide documentation for the provisions in FDA's interim final rule entitled ``Use of Materials Derived From Cattle in Human Food and Cosmetics.'' FDA is requiring recordkeeping because manufacturers and processors of human food and cosmetics need records to ensure that their products do not contain prohibited cattle materials, and records are necessary to help FDA ensure compliance with the requirements of the interim final rule.
Redetermination of Regulatory Review Period for Purposes of Patent Extension; BONIVA; Correction
Document Number: E6-16816
Type: Notice
Date: 2006-10-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of June 22, 2006 (71 FR 35918). The document announced that FDA had determined the regulatory review period for BONIVA. The notice provided that on or before August 21, 2006, anyone with knowledge that any of the dates as published are incorrect may submit a request for a redetermination of the regulatory review period. A request for revision of the regulatory review period was filed for the product on July 25, 2006. FDA reviewed its records and found that the effective date of the investigational new drug application (IND) was incorrect because of a clerical error. Therefore, FDA is republishing a determination of the regulatory review period to reflect the corrected effective date for the IND. FDA has made a determination of the regulatory review period because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that human drug product.
National Institute for Occupational Safety and Health (NIOSH); Advisory Board on Radiation and Worker Health
Document Number: E6-16747
Type: Notice
Date: 2006-10-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E6-16746
Type: Notice
Date: 2006-10-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: E6-16744
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644). A notice listing all currently certified laboratories is published in the Federal Register during the first week of each month. If any laboratory's certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end, and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at https:// workplace.samhsa.gov and https://www.drugfreeworkplace.gov.
CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment (CHACHSPT)
Document Number: E6-16739
Type: Notice
Date: 2006-10-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice of Meeting; Interagency Autism Coordinating Committee
Document Number: E6-16721
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
Request for Nominations for Voting Members on Public Advisory Panels or Committees
Document Number: E6-16679
Type: Notice
Date: 2006-10-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Device Good Manufacturing Practice Advisory Committee, certain device panels of the Medical Devices Advisory Committee, the National Mammography Quality Assurance Advisory Committee, and the Technical Electronic Products Radiation Safety Standards Committee in the Center for Devices and Radiological Health. Nominations will be accepted for current vacancies and those that will or may occur through August 31, 2007. FDA has a special interest in ensuring that women, minority groups, and individuals with disabilities are adequately represented on advisory committees and, therefore, encourages nominations of qualified candidates from these groups.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 06-8607
Type: Notice
Date: 2006-10-11
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) allow the proposed information collection project: ``Assessment of Unreimbursed Care among Community Primary Care Physicians.'' In accordance with the Paperwork Reduction Act of 1995, Public Law 104-13 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection.
National Institute of Neurological Disorders and Stroke; Cancellation of Meeting
Document Number: 06-8606
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed Meeting
Document Number: 06-8605
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Child Health and Human Development; Notices of Closed Meetings
Document Number: 06-8604
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: 06-8603
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
Clinical Center; Notice of Closed Meeting
Document Number: 06-8602
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: 06-8601
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
Notice of Meeting of the Advisory Committee on Minority Health
Document Number: 06-8596
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting is open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail acmb@osophs.dhhs.gov.
National Cancer Institute; Notice of Closed Meeting
Document Number: 06-8585
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Document Number: 06-8584
Type: Notice
Date: 2006-10-11
Agency: Department of Health and Human Services, National Institutes of Health
Medicare Program; Hospital Inpatient Prospective Payment Systems and Fiscal Year 2007 Rates: Final Fiscal Year 2007 Wage Indices and Payment Rates After Application of Revised Occupational Mix Adjustment to Wage Index
Document Number: 06-8471
Type: Notice
Date: 2006-10-11
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice contains tables listing the final occupational mix adjusted wage indices, hospital reclassifications, payment rates, impacts, and other related tables as a result of the application of the occupational mix adjustment to 100 percent of the wage index effective for fiscal year (FY) 2007.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.